Search Results - "Falk, S.J"

Colorectal Cancer by Gilbert, D.C, Falk, S.J

Get full text

Maximising recruitment into randomised controlled trials: The role of multidisciplinary cancer teams by McNair, A.G.K, Choh, C.T.P, Metcalfe, C, Littlejohns, D, Barham, C.P, Hollowood, A, Falk, S.J, Blazeby, J.M

“…Abstract Multidisciplinary cancer teams offer many theoretical benefits, although few have been formally examined. This study evaluated the role of…”
Get full text

A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer by Glynne-Jones, R., Sebag-Montefiore, D., Maughan, T. S., Falk, S. J., McDonald, A. C.

“…Purpose: To determine the maximum tolerated dose (MTD) of continuous oral capecitabine plus oxaliplatin and pre-operative pelvic radiotherapy (XELOX-RT)…”
Get full text

Upper GI 26 by Blazeby, J.M., Nicklin, J., Barham, C.P., Falk, S.J., Alderson, D.

“…Aims: Neo‐adjuvant chemoradiation before surgery for oesophageal cancer is designed to downstage loco‐regional disease and increase the chance of cure. Because…”
Get full text

A comparison of patients' and doctors' perception of symptom prevention: Results from a randomised trial of supportive treatment in advanced non-small cell lung cancer (NSCLC) by Girling, D.J, Falk, S.J, White, R.J, Qian, W

Get full text

Immediate versus delayed thoracic radiotherapy (TRT) in patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) and minimal symptoms: Results of an MRC/BTS randomised trial by Girling, D.J, Falk, S, White, R, Hopwood, P, Falk, S.J, White, R.J, Sambrook, R.J, Harvey, A, Qian, W, Stephans, R.J

Get full text

A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma by Ford, J.M., Stenning, S.P., Boote, D.J., Counsell, R., Falk, S.J., Flavin, A., Laurence, V.M., Bleehen, N.M.

“…Thirty-two patients prospectively identified as having poor prognosis high grade glioma, with a MRC prognostic score >25, were treated with a short palliative…”
Get full text

DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells by Falk, S J, Smith, P J

“…This study addressed the potential radiosensitizing and DNA-damaging actions of the DNA topoisomerase I poison camptothecin (CPT) on SV40 transformed normal…”
Get more information

BW12C perturbs normal and tumour tissue oxygenation and blood flow in man by Falk, S J, Ramsay, J R, Ward, R, Miles, K, Dixon, A K, Bleehen, N M

“…The effects of escalating doses of BW12C on normal tissue and tumour blood flow and pO2 in patients were studied. BW12C infusion resulted in a significant…”
Get more information

Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer by Ramsay, J R, Bleehen, N M, Dennis, I, Workman, P, Ward, R, Falk, S J, Bedford, P, Wootton, R, Nethersell, A B

“…The effect of combining the oxyhemoglobin-modifying drug BW12C with mitomycin C was investigated in a Phase I study of 18 patients with advanced…”
Get more information

Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer by Falk, S J, Maughan, T S, Laurence, V M, Lamont, A, Boote, D, Ford, J M, Osborne, R J, Bleehen, N M

“…A total of 25 patients with small cell lung cancer (SCLC) were treated with carboplatin and Adriamycin (CA) following symptomatic relapse after initial…”
Get more information